Skip to content
Search

Latest Stories

Wolverhampton pharmacist sentenced for Covid-19 grant fraud

The Pharmacist submitted eight grant applications containing “fake quotations” to the Relight Programme, seeking a total of £40,000 in funding.

Wolverhampton pharmacist Sundip Gill convicted for Covid-19 grant fraud

Pharmacist jailed for submitting “fake quotations” in Covid-19 grant applications

gettyimages

Sundip Gill, a registered pharmacist from Wolverhampton, has been sentenced to imprisonment after being found guilty of fraud related to Covid-19 grant applications.

According to the City of Wolverhampton Council, Gill made “false representations” and supplied “fake quotations” to support funding applications.


Gill is the director of two pharmaceutical companies, Sync Chem Ltd and Collateral Ltd, and operates four pharmacy businesses in Wolverhampton—Collateral, Your Pharmacy First, Low Hill Pharmacy, and Fallings Park Pharmacy.

During the Covid-19 pandemic, the government introduced grants to support local businesses.

As part of this initiative, the City of Wolverhampton Council launched the Relight Programme and allocated extra funding to help businesses improve their premises and increase carbon efficiency.

Businesses could apply for two grants and, if they met the qualifying criteria, could receive up to £5,000 for each successful application.

According to the council, Gill submitted eight grant applications to the programme and had the potential to receive a total of £40,000.

However, the council’s Counter Fraud Team were alerted to “discrepancies with the quotations” supplied by Gill.”

Upon investigations, it was discovered that Gill had submitted “fake quotations in support of his grant applications,” the council said.

“Following a detailed investigation, Gill was charged with 18 offences of dishonesty and Sync Chem Ltd and Collateral Ltd were charged with six offences of dishonesty, all under sections 1, 2 and 7 of the Fraud Act 2006,” it stated.

Gill denied the charges but was subsequently found guilty on all counts at Dudley Magistrates Court on 21 February.

He was sentenced to 20 weeks imprisonment, suspended for 12 months, ordered to complete 200 hours of unpaid work within a year. Additionally, he was ordered to pay £3,000 in costs and a £128 victim surcharge.

His two companies, Sync Chem Ltd and Collateral Ltd, were fined £14,690 and £8,690 respectively.

“You have been convicted for being fully involved in fraud and your attempts to exploit a system to assist legitimate businesses,” district judge Graham Wilkinson told Gill during sentencing.

He added that Gill had shown “no remorse.”

Councillor Louise Miles, cabinet member for resources at the City of Wolverhampton Council, condemned the abuse of the scheme, stating: “The Relight Programme was designed to support local business through, and to recover from, the Covid-19 pandemic, and not to be abused in the way that it was by Sundip Gill.”

She reaffirmed the council’s “zero tolerance” policy towards public sector fraud.

“It is far from a victimless crime, and its impacts ripple through our society, affecting every individual and the services we all rely on, and we will not hesitate to take action in instances like this,” she added.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less